Dr. Dawn Langdon is a Professor of Neuropsychology at Royal Holloway, University of London. She completed her BA studies in Experimental Psychology at the University of Oxford Saint Hilda's College in 1981, MPhil studies in Clinical Psychology at the Institute of Psychiatry Psychology and Neuroscience in 1983, and PhD studies in Neuropsychology at UCL Institute of Neurology, University College London, in 1993. Her research interests include the Benefits and Risks of MS Medication (BRIMMS), an evidence-based protocol that presents information about disease-modifying drugs in a way that increases the understanding of people with MS; developing the Motor Planning Index, a measure of cerebellar function for MS; and how cognition relates to the employment experience of people with MS.